We are live on ! Find out more
LNAI

Lunai Bioworks
LNAI

37 hedge funds and large institutions have $13.3M invested in Lunai Bioworks in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 2 increasing their positions, 22 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more capital invested

Capital invested by funds: $9.6M → $13.3M (+$3.67M)

0.01% less ownership

Funds ownership: 0.07% → 0.06% (-0.01%)

10% less funds holding

Funds holding: 41 → 37 (-4)

29% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 14

91% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 22

Holders
37
Holders Change
-4
Holders Change %
-9.76%
% of All Funds
0.64%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
2
Reduced
22
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$5.46M
2
Millennium Management
Millennium Management
New York
+$475K
3
VF
Virtu Financial
New York
+$277K
4
Truist Financial
Truist Financial
North Carolina
+$243K
5
E
Ergoteles
New York
+$196K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$3.34M
2
State Street
State Street
Massachusetts
-$633K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$595K
4
Northern Trust
Northern Trust
Illinois
-$500K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$214K

LNAI Hedge Fund Activity: Q2 2021 in Review

37 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q2 2021, worth a combined $13.3M — up 38% from $9.6M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of LNAI and 10 opened new positions — a net loss of 4 holders — while 22 trimmed existing stakes and 2 added.

The largest buyer was Sabby Management, opening a new position worth an estimated $5.46M. The largest seller was BlackRock, cutting an estimated $3.34M.

  • 37 institutional investors held Lunai Bioworks (LNAI) as of Q2 2021, down from 41 in Q1 2021.
  • Funds reported $13.3M of Lunai Bioworks stock for Q2 2021, up 38% quarter-over-quarter.
  • 10 funds opened new Lunai Bioworks positions in Q2 2021 and 14 closed out, a net change of -4 holders.
  • The largest Lunai Bioworks buyer in Q2 2021 was Sabby Management, an estimated $5.46M added.
  • The largest Lunai Bioworks seller in Q2 2021 was BlackRock, an estimated $3.34M sold.

Based on aggregated 13F filings for Q2 2021.